We found that the enhanced activation and antigen presentation induced by a UBC9 inhibitor, 2-D08, sensitized TAMs to promote CD8+ T cell–mediated cytotoxicity, and 2-D08 could also directly act on PCa cells to inhibit their proliferation. The gene discussed is UBE2I; the disease is posterior cortical atrophy.